The Potential of Technology to Improve Chronic Disease Management and Quality of Care
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
We seek to determine if patient data entry, data entered based alerts, and data review in a secure patient portal may provide a sustainable approach to improve diabetic outcomes in a cost effective manner. We plan to study the extent to which the portal can improve diabetic outcomes and quality of care. We recognize, however, that some patients will be more predisposed to adopting technology and some will be more predisposed to improving their compliance than others. Hence, we will also develop and test interventions that may improve adoption and compliance. The goals of the proposed study are: 1) to assess whether a web portal will improve care outcomes in diabetic patients; 2a) to describe the characteristics of patients whose health behavior improves over the study period; 2b) to describe the characteristics of patients who adopt the web portal-based disease management technology; 3) to develop and test targeted interventions to increase the adoption of the web portal and improve patient health behavior; and 4) to monitor the ongoing costs associated with the web portal and patient healthcare resource utilization, and to monitor the incremental costs of the interventions designed to improve utilization of the technology and patient compliance with their diabetic regimens.
| Condition | Intervention | Phase |
|---|---|---|
|
Diabetes Mellitus |
Behavioral: Patient diabetic self-management using the diabetic patient portal tools Behavioral: A variety of educational interventions for non-adopters of the technology, and for non-compliant patients. |
Phase 1 |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Efficacy Study Intervention Model: Crossover Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | The Potential of Technology to Improve Chronic Disease Management and Quality of Care |
- Clinical Outcome Measures: HbA1c, LDL,and the presence or absence of clinically significant proteinuria.
- Technology Adoption will be measured by tracking the patient usage of the various portal features
| Estimated Enrollment: | 1000 |
| Study Start Date: | September 2004 |
| Study Completion Date: | September 2007 |
To date, limited research has been conducted to determine if health information technology (HIT) is effective in improving the outcomes for patients with chronic diseases. Research is required to determine if interventions facilitated by an institutional EMR platform can be implemented such that they support patients with chronic diseases to achieve improved outcomes in a cost effective fashion.
At the Cleveland Clinic Foundation (CCF) an ambulatory EMR has been implemented to foster patient safety and institutional best practice guidelines, to facilitate research, and to achieve efficiencies in practice management. Our EMR is the foundation of the CCF patient portal. One of the functions of the portal is to allow patients to enter specific data elements that become part of their permanent medical record. Diabetics can enter and review their home glucometer readings, and view alert messages based on their entries. The entries are transferred to the patient's primary care physician's EMR In-Basket for review.
We recognize that some patients will be more predisposed to technology adoption and some will be more health behavior compliant than others. Therefore, in addition to studying our portal's efficacy in positive diabetic behavior change, we will test if interventions can assist less predisposed and less compliant patients to become more compliant and more inclined to adopt the technology.
The goals of the proposed study are:
1) to assess whether a web portal will improve care outcomes in diabetic patients; 2a) to describe the characteristics of patients whose health behavior improves over the study period; 2b) to describe the characteristics of patients who adopt the web portal-based disease management technology; 3) to develop and test targeted interventions to increase the adoption of the web portal and improve patient health behavior; 4) to monitor the ongoing costs associated with the web portal and patient healthcare resource utilization, and to monitor the incremental costs of the interventions designed to improve utilization of the technology and patient compliance with their diabetic regimens.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria: Diabetic patients 18 years of age or older with an established primary care physician at the Cleveland Clinic Foundation
Exclusion Criteria: An individual not meeting the inclusion criteria
Contacts and Locations| United States, Ohio | |
| The Cleveland Clinic Foundation | |
| Cleveland, Ohio, United States, 44195 | |
| Principal Investigator: | Martin Harris, MD, MBA | The Cleveland Clinic |
| Study Director: | Holly D Miller, MD, MBA | The Cleveland Clinic |
More Information
Additional Information:
Publications:
| ClinicalTrials.gov Identifier: | NCT00221455 History of Changes |
| Other Study ID Numbers: | 51760, 51760 |
| Study First Received: | September 15, 2005 |
| Last Updated: | July 25, 2011 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Robert Wood Johnson Foundation:
|
Diabetes Mellitus Chronic disease management Patient portal Patient empowerment |
Additional relevant MeSH terms:
|
Chronic Disease Diabetes Mellitus Disease Attributes Pathologic Processes |
Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases |
ClinicalTrials.gov processed this record on May 22, 2013